Financials
EPRX Eupraxia Pharmaceuticals, In.. (TOR)
-
- Last: 7.750
- Change: -0.72 (-8.50%)
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|
| Net Income | -35.27 M | -39.10 M | -23.92 M | -23.37 M |
| Depreciation and Amortization | 235.25 K | 209.91 K | 193.27 K | 111.53 K |
| Amortization of Goodwill and Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Impairment of Oil, Gas and Mineral Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| (Gain) Loss from Sale of Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Gain) Loss from Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Provision for Credit Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Provision and Write-Off of Bad Debts | N/A | N/A | N/A | N/A |
| (Income) Loss on Equity Investment | -192.62 K | 248.32 K | 677.96 K | 339.57 K |
| Minority Interest in Earnings | -331.47 K | -1.01 M | -657.84 K | -379.95 K |
| Net Cash from Discontinued Operations | N/A | N/A | N/A | N/A |
| Other Operating Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Accounts Receivable | -138.90 K | -139.98 K | 310.06 K | 190.89 K |
| Change in Inventories | N/A | N/A | N/A | N/A |
| Change in Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Unearned Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Deferred Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Other Net Operating Assets | -8.15 M | 6.58 M | -20.53 K | 65.17 K |
| Cash from Operating Activities | -41.09 M | -27.92 M | -18.78 M | -14.64 M |
| Sale of Property, Plant and Equipment | 39.82 K | 0.00 | 310.00 | 0.00 |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Investment in Marketable and Equity Securities | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | -5.02 M |
| Cash from Investing Activities | -102.97 K | -99.04 K | 8.70 M | -14.45 M |
| Short Term Debt Issued | 0.00 | 0.00 | 0.00 | 0.00 |
| Long Term Debt Issued | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 0.00 |
| Short Term Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 |
| Long Term Debt Repaid | -85.83 K | -107.22 K | -97.49 K | 0.00 |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends Paid | N/A | 0.00 | 0.00 | 0.00 |
| Common and/or Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 62.72 M | 28.36 M | 13.52 M | 49.92 M |
| Foreign Exchange Rate Adjustment | -2.68 M | 1.11 M | 396.83 K | -81.63 K |
| Net Change in Cash | 18.85 M | 1.46 M | 3.84 M | 20.74 M |
Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement.
Canadian Mutual Fund and ETF data provided by Fundata Canada Inc. Press Releases provided by Comtex News Network.